Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Emory University
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Adela, Inc
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Mayo Clinic
University of Southern California
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
AVM Biotechnology Inc
Washington University School of Medicine
University College, London
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Tempus AI
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
University of South Florida
Medical College of Wisconsin
Cedars-Sinai Medical Center
Case Comprehensive Cancer Center
BeiGene
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Martin-Luther-Universität Halle-Wittenberg
University of Virginia
N.N. Petrov National Medical Research Center of Oncology
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
Lumos Pharma
National Cancer Institute (NCI)
Meyer Children's Hospital IRCCS
Masonic Cancer Center, University of Minnesota
University of Alabama at Birmingham
Medical University of Vienna
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Centre Leon Berard
Hoffmann-La Roche
Canadian Cancer Trials Group